Amyloid precursor protein processing and Aβ <sub>42</sub> deposition in a transgenic mouse model of Alzheimer disease
Kelly Johnson‐Wood, Lisa McConlogue(Gladstone Institutes), Dora Games(Athena Group (United States)), Marcia N. Gordon(Grand Rapids Community College), Karen Khan, Peter Seubert(Sunesis (United States)), Ruth Motter, Hua Tan(Sunesis (United States)), Robin Barbour(Sunesis (United States)), Ivan Lieberburg(Sunesis (United States)), Kang Hu, Grace Gordon(Athena Group (United States)), Dale Schenk(Athena Group (United States)), M. Lee(Athena Group (United States))
Cited by 659
Related Papers
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
|Nature|1995|2.5k
High-Level Neuronal Expression of Aβ<sub>1–42</sub>in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation
|Journal of Neuroscience|2000|1.9k